| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-04-10 |
详情>>
股本变动：
变动后总股本3266.45万股
|
| 2020-04-10 |
详情>>
业绩披露：
2019年年报每股收益-5.47美元,归母净利润-1.64亿美元,同比去年增长18.14%
|
| 2020-04-07 |
复牌提示：
2020-04-07 06:47:36 停牌，复牌日期 2020-04-07 12:16:00
|
| 2020-03-09 |
详情>>
内部人交易：
MCCARD RAY HAROLD JR等共交易8笔
|
| 2019-11-07 |
财报披露：
美东时间 2019-11-07 盘后发布财报
|
| 2019-11-07 |
详情>>
业绩披露：
2019年三季报(累计)每股收益-4.41美元,归母净利润-1.32亿美元,同比去年增长26.58%
|
| 2019-08-07 |
详情>>
业绩披露：
2019年中报每股收益-1.88美元,归母净利润-5587.9万美元,同比去年增长55.50%
|
| 2019-05-10 |
详情>>
业绩披露：
2019年一季报每股收益-1.33美元,归母净利润-3900.6万美元,同比去年增长60.59%
|
| 2019-04-19 |
股东大会：
将于2019-05-31召开股东大会
会议内容 ▼▲
- 1.To elect eight nominees for director of the Company, nominated by the Board of Directors, with each director to serve until the 2020 annual meeting of the stockholders of the Company and until his or her successor is elected and qualified;
2.To approve the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan;
3.To approve the Quorum Health Corporation 2018 Restricted Stock Plan;
4.To approve, in an advisory (non-binding) vote, the compensation of the Company’s named executive officers, as more fully described in the accompanying proxy statement (“say-on-pay”);
5.To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the year ending December 31, 2019;
6.To transact such other business as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2019-03-12 |
详情>>
业绩披露：
2018年年报每股收益-6.91美元,归母净利润-2亿美元,同比去年增长-75.36%
|
| 2019-03-12 |
详情>>
业绩披露：
2016年年报每股收益-12.24美元,归母净利润-3.48亿美元,同比去年增长-26105.09%
|
| 2018-11-06 |
详情>>
业绩披露：
2018年三季报(累计)每股收益-6.21美元,归母净利润-1.8亿美元,同比去年增长-105.44%
|
| 2018-08-09 |
详情>>
业绩披露：
2018年中报每股收益-4.37美元,归母净利润-1.26亿美元,同比去年增长-115.8%
|
| 2018-05-10 |
详情>>
业绩披露：
2018年一季报每股收益-3.48美元,归母净利润-9896.8万美元,同比去年增长-259.09%
|
| 2018-04-27 |
股东大会：
将于2018-06-08召开股东大会
会议内容 ▼▲
- 1.To elect seven nominees for director of the Company, nominated by the Board of Directors, with each director to serve until the 2019 annual meeting of the stockholders of the Company and until his or her successor is elected and qualified;
2.To approve, in an advisory (non-binding) vote, the compensation of the Company’s named executive officers as described in the accompanying proxy statement (“say-on-pay”);
3.To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the year ending December 31, 2018;
4.To transact such other business as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2018-03-15 |
详情>>
业绩披露：
2017年年报每股收益-4.06美元,归母净利润-1.14亿美元,同比去年增长67.16%
|
| 2017-04-13 |
股东大会：
将于2017-05-16召开股东大会
会议内容 ▼▲
- 1.To elect eight nominees for director of the Company, nominated by the Board of Directors, with each director to serve until the 2018 annual meeting of the stockholders of the Company and until his or her successor is elected and qualified;
2.To approve, in an advisory (non-binding) vote, the compensation of the Company’s named executive officers as described in the accompanying proxy statement (“say-on-pay”);
3.To approve, in an advisory (non-binding) vote, as to whether a stockholder vote to approve the compensation of the Company’s named executive officers should occur every one, two or three years (“say-on-frequency”);
4.To approve, for purposes of Section 162(m) of the Internal Revenue Code, the material terms of our 2016 Employee Performance Incentive Plan;
5.To approve, for purposes of Section 162(m) of the Internal Revenue Code, the material terms of our 2016 Stock Award Plan;
6.To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the year ending December 31, 2017;
7.To transact such other business as may properly come before the meeting or any postponement or adjournment of the meeting.
|